New Deal
SAVED SEARCHES
NO SAVED SEARCHES
Automate your research and never miss a deal that matters to you.
Deals (68)
Dealmakers
Service Providers
Funds
Corporates
FILTER
0
Value
Date
Country
Sector
Deal Type
Export
SORT
Announcement Date
Deal Value
Amolyt Pharma
ASTRAZENECA
£820m
26 dealmakers
BIOMX
Adaptive Phage Therapeutics
value n/a
14 dealmakers
Mainstay Medical Holdings
Gilde Healthcare
£98m
7 dealmakers
BIOAGE
Rtw Investments
£134m
5 dealmakers
Cymabay Therapeutics
Gilead Sciences
£3,404m
30 dealmakers
Rain Oncology
Pathos Ai
33 dealmakers
Meiragtx Holdings
Sanofi
£24m
6 dealmakers
Medicx Health
OPTIMIZERX
£77m
Pionyr Immunotherapeutics
Ikena Oncology
25 dealmakers
Proqr (sepofarsen And Ultevursen)
Laboratoires Thea
£10m
Biosight
Ayala Pharmaceuticals
NOVAN
Ligand Pharmaceuticals
£11m
MORPHIMMUNE
IMMUNOME
£102m
19 dealmakers
Reunion Neuroscience
Mpm Bioimpact
9 dealmakers
Satsuma Pharmaceuticals
Shin Nippon Biomed Lab
£177m
Enzo Biochem (clinical Laboratory)
LABCORP
Noema Pharma
£93m
Vbl Therapeutics
Notable Labs
Elicio Therapeutics
Angion Biomedica Corp
Cincor Pharma
Astrazeneca
£1,487m
79 dealmakers
Albireo Pharma
IPSEN
£786m
29 dealmakers
Amryt Pharma
Chiesi Farmaceutici
£1,223m
44 dealmakers
Tekla Capital Management
£115m
18 dealmakers
Soleno Therapeutics
Nantahala Capital Management
£49m
3 dealmakers
Aeon Biopharma
Priveterra Acquisition Corp
£387m
20 dealmakers
Eleusis Therapeutics
Beckley Psytech
8 dealmakers
Advaxis
12 dealmakers
Aveo Oncology
Lg Chem
£500m
BIOLOG-ID
Genesis Growth Tech Acquisition Corp
£264m
10 dealmakers
Oncotype Dx Gps
MDXHEALTH
£81m
4 dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.